| Dr. Dinesh Patel |
| |
 |
| |
| Dr. Dinesh Patel - popularly known as the father of biotechnology
and pharmaceuticals in the Mountain West region, is the Chairman
of the Board of Directors at AcuNova Life Science Inc. He
is the Founder, Chairman, President & CEO of Ashni Naturaceuticals,
Inc., a company that specializes in the research, development
and marketing of clinically tested and patent-protected naturaceutical
products. Prior to vSpring, he co-founded and served as Chairman
and CEO of TheraTech, a biotechnology company, which was sold
for $350 million to Watson Therapeutics soon after a successful
IPO. Dr. Dinesh was also a Co-Founder and Founding CEO and
Chairman of Salus Therapeutics. Dr. Dinesh has led investments
in Altea Therapeutics, Exagen, Pharmadigm, Protolex, Q Therapeutics,
and Salus Therapeutics |
| |
| Dr. Patel serves on several non-profit boards, and has won
numerous awards including; 2006 Ellis Island Medal of Honor,
US Small Business Administration's Business Achiever Award,
Scientific and Technology Award (State of Utah), Entrepreneur
of the Year Award (Mountain West Venture Group) and Scientific
and Technology Development Pioneer of Progress Award to name
a few. He is also a charter member of The Indus Entrepreneurs
(TiE). Dr. Patel served as co-chair of Governor Huntsman's
transition team and is currently on the board of the Utah
Policy Partnership (UPP). He was recently appointed the Chairman
of the USTAR Governing Authority board. |
| |
| Dr. Patel received his bachelor's degree in Pharmacy at
Gujarat University, (Ahmedabad) and his master's degree from
the Philadelphia College of Pharmacy. He has received his
Ph.D. in Physical Pharmacy from the University of Michigan.
|
| |
| > next |